A mouse model for human atherosclerosis: Long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice

Acta Histochemica

Volumn 108, Issue 6, 2006, Pages 415-424

  Coleman, Raymond ^a   Hayek, Tony ^a,b   Keidar, Shlomo ^a,b   Aviram, Michael ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Aortic arch; Apolipoprotein E deficiency; Atherosclerosis; Histopathology; Mice; Review

Indexed keywords

ALKALINITY; BIODIVERSITY; CELLS; CHOLESTEROL; PROTEINS;

AORTIC ARCH; APOLIPOPROTEIN E-DEFICIENCY; ATHEROSCLEROSIS; HISTOPATHOLOGY;

PATHOLOGY;

APOLIPOPROTEIN E; CHOLESTEROL; EPOXY RESIN; FAT; LIPID; TOLONIUM CHLORIDE; WAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOACCUMULATION; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL OCCLUSION; CELL DEGENERATION; CELL STRUCTURE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; LIPOGENESIS; MACROPHAGE; MOUSE; MUSCLE CELL; NONHUMAN; OPTICAL RESOLUTION; PATHOGENESIS; PROTEIN DEFICIENCY; QUANTITATIVE ANALYSIS; REVIEW; STAINING; SUBENDOTHELIUM; TISSUE SECTION; TUNICA MEDIA;

EID: 33750718119     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2006.07.002     Document Type: Review

References (21)

1. Aviram M., Dornfeld L., Rosenblat M., Volkova N., Kaplan M., Coleman R., et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71 (2000) 1062-1076
2. Cunningham K.S., and Gotlieb A.I. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest 85 (2005) 9-23
3. Davignon J., Cohn J.S., Mabile L., and Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 286 (1999) 115-143
4. Fuhrman B., Rosenblat M., Hayek T., Coleman R., and Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 130 (2000) 1124-1131
5. 0) mice and reduce macrophage atherogenicity. J Nutr 135 (2005) 722-728
6. Hayek T., Kaplan M., Raz A., Keidar S., Coleman R., and Aviram M. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis. Atherosclerosis 161 (2002) 65-74
7. Hayek T., Hamoud S., Keidar S., Pavlotzky E., Coleman R., Aviram M., et al. Omapatrilat decreased macrophage oxidative status and atherosclerosis progression in atherosclerotic apolipoprotein deficient mice. J Cardiovasc Pharmacol 43 (2004) 140-147
8. Kaplan M., Hayek T., Raz A., Coleman R., Dornfeld L., Vaya J., et al. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr 131 (2001) 2082-2089
9. Keidar S., Hayek T., Kaplan M., Pavlotzky E., Hamoud S., Coleman R., et al. Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice. J Cardiovasc Pharmacol 41 (2003) 955-963
10. Keidar S., Kaplan M., Pavlotzky E., Coleman R., Hayek T., Hamoud S., et al. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increased atherosclerosis development. A possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 109 (2004) 2213-2220
11. Lusis A.J. Atherosclerosis. Nature 407 (2000) 233-241
12. Meir K.S., and Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse. A decade of progress. Arterioscler Thromb Vasc Biol 24 (2004) 1006-1014
13. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14 (1994) 133-140
14. Paigen B., Ishida B.Y., Verstuyft J., Winters R.B., and Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis 10 (1990) 316-323
15. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Proc Natl Acad Sci USA 89 (1992) 4471-4475
16. 0 mice created by homologous recombination in ES cells. Cell 71 (1992) 343-353
17. Rattazzi M., Bennett B.J., Bea F., Kirk E.A., Ricks J.L., Speer M., et al. Calcification of advanced atherosclerotic lesions in innominate arteries of apoE-deficient mice. Potential role of chondrocyte-like cells. Arterioscler Thromb Vasc Biol 25 (2005) 1420-1425
18. Reddick R.L., Zhang S.H., and Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14 (1994) 141-147
19. Rosenblat M., Coleman R., and Aviram M. Increased macrophage gluathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 163 (2002) 17-28
20. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
21. Shamir R., Shehadeh N., Rosenblat M., Eshach-Adiv O., Coleman R., Kaplan M., et al. Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23 (2003) 104-110